Dianthus Therapeutics (DNTH) Financials: Revenue & Earnings
DNTH$79.22-0.30 -0.38%
$4.43B
Market Cap
-605.77
P/E
27.57
Forward P/E
45
Score
Dianthus Therapeutics (DNTH) Financials: Revenue & Earnings
DNTH price $79.22 -0.30 -0.38%
- Ticker
- DNTH
- Price
- $79.22
- Change
- -0.30 -0.38%
- Market cap ?
- $4.43B
- P/E ?
- -605.77
- Forward P/E ?
- 27.57
- Dividend yield ?
- 0.00%
- Beta ?
- 0.08
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 45
- Value
- 57
- Quality
- 29
- Growth
- 50
Stocklytics score rationale: value 57, quality 29, growth 50.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 1476000 | 6417000 | 2826000 | 6235000 | 2036000 |
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid…
Fair value
DNTH fair value $49.30. Price $79.22. Price is 61% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 257.76K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 55.93M. Net debt -49.70M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.94 | — | 460.93K |
| 2026-08-04 | -0.90 | -0.85 | 761.00K | 297.18K |
| 2026-05-05 | -0.85 | -1.17 | 463.00K | 403.62K |
| 2026-03-09 | -1.43 | -0.98 | 284.00K | 552.23K |
| 2025-11-05 | -0.97 | -0.86 | 396.00K | 576.00K |
| 2025-08-07 | -0.88 | -0.86 | 193.00K | 858.20K |
| 2025-05-12 | -0.82 | -0.86 | 1.16M | 806.90K |
| 2025-03-11 | -0.81 | -0.85 | 1.32M | 955.22K |
| 2024-11-07 | -0.74 | -0.59 | 2.17M | 741.14K |
| 2024-08-08 | -0.51 | -0.55 | 1.86M | 368.86K |
| 2024-05-09 | -0.54 | -0.43 | 874.00K | 464.25K |
| 2024-03-21 | -0.71 | -1.11 | 457.00K | 548.50K |
| 2023-11-09 | -3.78 | -0.51 | 924.00K | 250.00K |
| 2023-08-03 | -3.12 | -0.80 | 1.00M | — |
| 2023-05-15 | -7.52 | -6.40 | 476.00K | — |
| 2022-11-03 | -4.32 | -4.64 | 1.17M | — |
| 2022-08-04 | -4.64 | -5.44 | — | — |
| 2022-05-16 | -6.24 | -5.09 | — | — |
| 2022-03-08 | -5.25 | — | — | — |
| 2021-11-04 | -4.76 | — | — | — |
| 2021-08-05 | -5.04 | — | — | — |
| 2021-05-06 | -5.76 | — | — | — |
| 2021-03-03 | -5.99 | — | — | — |
| 2020-11-05 | -5.86 | — | — | — |
| 2020-08-06 | -7.71 | — | — | — |
| 2020-05-07 | -8.13 | — | — | — |
| 2020-03-03 | -9.52 | — | — | — |
| 2019-11-13 | -8.65 | — | — | — |
| 2019-08-08 | -7.73 | — | — | — |
| 2019-05-09 | -7.10 | — | — | — |
| 2019-03-19 | -8.04 | — | — | — |
| 2018-11-08 | -7.77 | — | — | — |
| 2018-08-09 | -6.39 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-17 | CARR EDWARD | Sell | 20.00K | $17.88 | 357.60K |
| 2026-09-17 | CARR EDWARD | Buy | 20.00K | $17.88 | 357.60K |
| 2026-09-17 | CARR EDWARD | Sell | 7.93K | $100.43 | 796.21K |
| 2026-09-17 | CARR EDWARD | Sell | 6.77K | $101.37 | 686.38K |
| 2026-09-17 | CARR EDWARD | Sell | 3.50K | $102.39 | 358.47K |
| 2026-09-17 | CARR EDWARD | Sell | 1.10K | $103.20 | 113.52K |
| 2026-09-17 | CARR EDWARD | Sell | 700 | $104.39 | 73.07K |
| 2026-09-01 | Randhawa Simrat | Sell | 9.38K | $22.07 | 206.91K |
| 2026-09-01 | Randhawa Simrat | Sell | 7.50K | $17.88 | 134.10K |
| 2026-09-01 | Randhawa Simrat | Sell | 6.25K | $21.77 | 136.04K |
| 2026-09-01 | Randhawa Simrat | Buy | 9.38K | $22.07 | 206.91K |
| 2026-09-01 | Randhawa Simrat | Sell | 2.60K | $105.19 | 273.49K |
| 2026-09-01 | Randhawa Simrat | Buy | 6.25K | $21.77 | 136.04K |
| 2026-09-01 | Randhawa Simrat | Sell | 7.21K | $106.25 | 766.59K |
| 2026-09-01 | Randhawa Simrat | Buy | 7.50K | $17.88 | 134.10K |
| 2026-09-01 | Randhawa Simrat | Sell | 13.31K | $106.74 | 1.42M |
| 2026-08-19 | Read Simon | Sell | 2.78K | $18.36 | 51.00K |
| 2026-08-19 | Read Simon | Buy | 2.78K | $18.36 | 51.00K |
| 2026-08-19 | Read Simon | Sell | 2.78K | $117.55 | 326.55K |
| 2026-08-13 | Veness Adam M | Sell | 15.00K | $18.17 | 272.55K |
| 2026-08-13 | Veness Adam M | Buy | 15.00K | $18.17 | 272.55K |
| 2026-08-10 | McGeorge Anne | Buy | 6.50K | $11.20 | 72.80K |
| 2026-08-10 | McGeorge Anne | Sell | 1.45K | $107.58 | 155.99K |
| 2026-08-10 | McGeorge Anne | Sell | 2.80K | $108.38 | 303.46K |
| 2026-08-10 | McGeorge Anne | Sell | 1.80K | $109.30 | 196.74K |
| 2026-08-10 | McGeorge Anne | Buy | 1.25K | $19.36 | 24.20K |
| 2026-08-10 | McGeorge Anne | Sell | 1.00K | $110.64 | 110.64K |
| 2026-08-10 | McGeorge Anne | Sell | 6.50K | $11.20 | 72.80K |
| 2026-08-10 | McGeorge Anne | Sell | 700 | $111.41 | 77.99K |
| 2026-08-10 | McGeorge Anne | Sell | 1.25K | $19.36 | 24.20K |
| 2026-08-10 | Read Simon | Sell | 2.78K | $18.36 | 50.99K |
| 2026-08-10 | Read Simon | Buy | 2.78K | $18.36 | 50.99K |
| 2026-08-10 | Read Simon | Sell | 70 | $107.11 | 7.50K |
| 2026-08-10 | Read Simon | Sell | 737 | $108.17 | 79.72K |
| 2026-08-10 | Read Simon | Sell | 831 | $108.95 | 90.54K |
| 2026-08-10 | Read Simon | Sell | 272 | $109.96 | 29.91K |
| 2026-08-10 | Read Simon | Sell | 470 | $111.05 | 52.19K |
| 2026-08-10 | Read Simon | Sell | 397 | $111.77 | 44.37K |
| 2026-08-10 | Veness Adam M | Sell | 16.17K | $17.88 | 289.07K |
| 2026-08-10 | Veness Adam M | Buy | 16.17K | $17.88 | 289.07K |
| 2026-08-10 | Veness Adam M | Sell | 16.17K | $110.38 | 1.78M |
| 2026-08-07 | Veness Adam M | Sell | 3.83K | $17.88 | 68.53K |
| 2026-08-07 | Veness Adam M | Buy | 3.83K | $17.88 | 68.53K |
| 2026-08-07 | Veness Adam M | Sell | 3.22K | $110.61 | 355.83K |
| 2026-08-07 | Veness Adam M | Sell | 616 | $111.18 | 68.49K |
| 2026-08-07 | Garcia Marino | Sell | 40.00K | $8.44 | 337.60K |
| 2026-08-07 | Garcia Marino | Buy | 126.00K | $8.44 | 1.06M |
| 2026-08-07 | Garcia Marino | Sell | 10.38K | $107.49 | 1.12M |
| 2026-08-07 | Garcia Marino | Sell | 23.91K | $108.05 | 2.58M |
| 2026-08-07 | Garcia Marino | Sell | 2.37K | $109.10 | 258.89K |
| 2026-08-07 | Garcia Marino | Sell | 2.54K | $110.02 | 279.01K |
| 2026-08-07 | Garcia Marino | Sell | 800 | $110.76 | 88.61K |
| 2026-08-07 | Garcia Marino | Sell | 126.00K | $8.44 | 1.06M |
| 2026-08-07 | Garcia Marino | Buy | 40.00K | $8.44 | 337.60K |
| 2026-08-07 | Garcia Marino | Sell | 104.09K | $107.96 | 11.24M |
| 2026-08-07 | Garcia Marino | Sell | 21.91K | $108.72 | 2.38M |
| 2026-07-09 | Savitz Ryan | Sell | 31.25K | $21.77 | 680.29K |
| 2026-07-09 | Savitz Ryan | Buy | 31.25K | $21.77 | 680.29K |
| 2026-07-09 | Savitz Ryan | Sell | 10.35K | $100.22 | 1.04M |
| 2026-07-09 | Savitz Ryan | Sell | 15.33K | $101.24 | 1.55M |
| 2026-07-09 | Savitz Ryan | Sell | 5.57K | $101.97 | 567.57K |
| 2026-06-17 | Veness Adam M | Sell | 30.00K | $17.88 | 536.40K |
| 2026-06-17 | Veness Adam M | Buy | 30.00K | $17.88 | 536.40K |
| 2026-06-17 | Veness Adam M | Sell | 16.77K | $80.34 | 1.35M |
| 2026-06-17 | Veness Adam M | Sell | 13.23K | $81.38 | 1.08M |
| 2026-06-01 | Randhawa Simrat | Sell | 9.38K | $22.07 | 206.91K |
| 2026-06-01 | Randhawa Simrat | Sell | 6.91K | $17.88 | 123.52K |
| 2026-06-01 | Randhawa Simrat | Sell | 6.25K | $21.77 | 136.04K |
| 2026-06-01 | Randhawa Simrat | Buy | 9.38K | $22.07 | 206.91K |
| 2026-06-01 | Randhawa Simrat | Sell | 5.43K | $89.72 | 487.00K |
| 2026-06-01 | Randhawa Simrat | Buy | 6.25K | $21.77 | 136.04K |
| 2026-06-01 | Randhawa Simrat | Buy | 6.91K | $17.88 | 123.52K |
| 2026-06-01 | Randhawa Simrat | Sell | 16.94K | $90.72 | 1.54M |
| 2026-06-01 | Randhawa Simrat | Buy | 4.00K | $8.44 | 33.74K |
| 2026-06-01 | Randhawa Simrat | Sell | 4.16K | $91.37 | 380.01K |
| 2026-06-01 | Randhawa Simrat | Sell | 4.00K | $8.44 | 33.74K |
| 2026-05-21 | Romano Steven J. | Buy | 6.09K | $89.63 | 545.85K |
| 2026-05-21 | Read Simon | Buy | 6.09K | $89.63 | 545.85K |
| 2026-05-21 | Lawton Alison Frances | Buy | 6.09K | $89.63 | 545.85K |
| 2026-05-21 | McGeorge Anne | Buy | 6.09K | $89.63 | 545.85K |
| 2026-05-21 | KANGO SUJAY | Buy | 6.09K | $89.63 | 545.85K |
| 2026-05-21 | Violin Jonathan | Buy | 6.09K | $89.63 | 545.85K |
| 2026-05-21 | Soteropoulos Paula | Buy | 6.09K | $89.63 | 545.85K |
| 2026-05-08 | Soteropoulos Paula | Buy | 599 | $8.44 | 5.06K |
| 2026-05-08 | Soteropoulos Paula | Sell | 599 | $85.47 | 51.20K |
| 2026-05-08 | Soteropoulos Paula | Sell | 599 | $8.44 | 5.06K |
| 2026-04-09 | Savitz Ryan | Sell | 8.22K | $17.88 | 147.05K |
| 2026-04-09 | Savitz Ryan | Buy | 8.22K | $17.88 | 147.05K |
| 2026-04-09 | Savitz Ryan | Sell | 8.22K | $89.84 | 738.84K |
| 2026-03-31 | Savitz Ryan | Buy | 40.00K | $17.88 | 715.20K |
| 2026-03-31 | Savitz Ryan | Sell | 1.39K | $78.33 | 108.88K |
| 2026-03-31 | Savitz Ryan | Sell | 21.82K | $78.86 | 1.72M |
| 2026-03-31 | Savitz Ryan | Sell | 1.49K | $80.25 | 119.17K |
| 2026-03-31 | Savitz Ryan | Sell | 800 | $81.36 | 65.09K |
| 2026-03-31 | Savitz Ryan | Sell | 2.37K | $82.84 | 196.00K |
| 2026-03-31 | Savitz Ryan | Sell | 40.00K | $17.88 | 715.20K |
| 2026-03-31 | Savitz Ryan | Buy | 74.37K | $8.44 | 627.66K |
| 2026-03-31 | Savitz Ryan | Sell | 59.80K | $83.90 | 5.02M |
| 2026-03-31 | Savitz Ryan | Sell | 74.37K | $8.44 | 627.66K |
| 2026-03-31 | Savitz Ryan | Sell | 19.47K | $84.57 | 1.65M |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 279, holders +29 vs prior quarter. Ownership 137.66%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FMR LLC | 8.20M | 432.21K | +5.56% | 799.33M |
| BLACKROCK, INC. | 4.12M | 948.12K | +29.86% | 401.99M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 3.89M | 2.60M | +200.92% | 379.05M |
| WELLINGTON MANAGEMENT GROUP LLP | 3.23M | 634.10K | +24.43% | 314.85M |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 2.54M | 0 | 0.00% | 247.33M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.51M | 1.37M | +119.27% | 245.16M |
| STATE STREET CORP | 2.36M | 958.53K | +68.52% | 229.80M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.16M | 128.32K | +6.32% | 210.51M |
| AVIDITY PARTNERS MANAGEMENT LP | 2.10M | 0 | 0.00% | 205.12M |
| OCTAGON CAPITAL ADVISORS LP | 1.84M | -105.00K | -5.39% | 179.53M |
| TCG CROSSOVER MANAGEMENT, LLC | 1.68M | 0 | 0.00% | 163.44M |
| FRED ALGER MANAGEMENT, LLC | 1.30M | 140.57K | +12.10% | 126.97M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.26M | 342.29K | +37.36% | 122.70M |
| VENROCK ADVISER, LLC | 1.18M | 0 | 0.00% | 115.03M |
| UBS GROUP AG | 1.14M | 358.98K | +45.95% | 111.15M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.13M | 105.50K | +10.35% | 109.70M |
| JENNISON ASSOCIATES LLC | 1.02M | 536.63K | +110.61% | 99.60M |
| POLAR CAPITAL HOLDINGS PLC | 1.02M | -57.28K | -5.32% | 99.31M |
| CITADEL ADVISORS LLC | 974.91K | -635.57K | -39.46% | 95.03M |
| FRANKLIN TEMPLETON INC | 968.98K | 801 | +0.08% | 94.46M |
| BAKER BROS. ADVISORS LP | 852.16K | 0 | 0.00% | 83.07M |
| LOGOS GLOBAL MANAGEMENT LP | 800.00K | 400.00K | +100.00% | 77.98M |
| CORMORANT ASSET MANAGEMENT, LP | 750.00K | -200.00K | -21.05% | 73.11M |
| ALLIANCEBERNSTEIN L.P. | 834.15K | -91.92K | -9.93% | 70.00M |
| BRAIDWELL LP | 594.56K | -304.80K | -33.89% | 57.96M |
Earnings and financials
Dianthus Therapeutics, Inc. (DNTH) trades at $79.22, with a market cap of $4.43B and a trailing P/E of -605.77. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 1476000 | 6417000 | 2826000 | 6235000 | 2036000 |
Insights · Dividends · Forecast · Financials · Learn